|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:Roche
|
|
gptkbp:acquired
|
gptkb:Roche
|
|
gptkbp:awards
|
various industry awards
|
|
gptkbp:ceo
|
gptkb:M._R._(Marty)_Tenenbaum
|
|
gptkbp:clinical_trial
|
various cancer types
|
|
gptkbp:collaborations
|
academic institutions
pharmaceutical companies
research organizations
|
|
gptkbp:employees
|
over 500
|
|
gptkbp:focus
|
genomic profiling
|
|
gptkbp:founded
|
gptkb:2010
|
|
gptkbp:founder
|
gptkb:M._R._(Marty)_Tenenbaum
|
|
gptkbp:goal
|
gptkb:healthcare_organization
personalized medicine
improving patient outcomes
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Foundation Medicine
|
|
gptkbp:impact
|
cancer research
clinical practice
healthcare industry
|
|
gptkbp:mission
|
transform cancer care
|
|
gptkbp:partnership
|
gptkb:Eli_Lilly
gptkb:Merck
gptkb:GSK
gptkb:temple
gptkb:Sanofi
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Amgen
gptkb:National_Comprehensive_Cancer_Network
gptkb:Novartis
|
|
gptkbp:regulatory_compliance
|
gptkb:CLIA
gptkb:FDA
|
|
gptkbp:research
|
molecular diagnostics
therapeutic development
cancer genomics
|
|
gptkbp:services
|
gptkb:Foundation_One_Heme
gptkb:Foundation_One_Liquid
Foundation One C Dx
|
|
gptkbp:symbol
|
FMI
|
|
gptkbp:technology
|
data analytics
bioinformatics
next-generation sequencing
|
|
gptkbp:type
|
gptkb:Company
|
|
gptkbp:vision
|
a world where every patient has access to personalized medicine.
|
|
gptkbp:website
|
foundationmedicine.com
|